Plenarreferate: Eröffnung
-
Plenary
/ Panel
| |||||
| |||||
| |||||
| |||||
| |||||
|
M. Phil., M.Sc., BA Hons. Justine BURLEY
Associate Professor and Deputy Executive Director, Graduate School for Integrative Sciences & Engineering (NGS), National University of Singapore
Post-graduate degrees in both political philosophy, and in neuroscience from the University of Oxford | |
1993-2002 | Lecturership at the University of Oxford
Dr. Alan COLMAN
Principal Investigator, Institute of Medical Biology and Executive Director, Singapore Stem Cell Consortium, Agency for Science, Technology and Research (A*STAR), Singapore; Professor of Regenerative Medicine and Director, Stem Cell Centre, King's College London
1974-1976 | Demonstrator in Developmental Biology, Zoology Department, Oxford University
1976-1983 | Lecturer in Department of Biological Sciences, University of Warwick, Coventry
1983-1987 | Senior Lecturer, Department of Biological Sciences, University of Warwick, Coventry
1987-1993 | Professor, Department of Biochemistry, University of Birmingham
1988-1993 | Research Director, PPL Therapeutics plc, Edinburgh, UK (part-time)
1993-2002 | Research Director, PPL Therapeutics plc, Edinburgh, UK (full-time)
2002-2005 | Chief Scientific Officer, ES Cell International, Singapore
since 2002 | Adjunct Professor, Department of Biochemistry, National University of Singapore
since 2004 | Senior Scientist, Center for Molecular Medicine, Biomedical research Institute, Singapore
2005-2007 | Chief Executive Officer, ES Cell International, Singapore
since 2007 | Executive Director of the A*STAR Stem Cell Consortium
Dr. William FOEGE
Epidemiologist, Presidential Distinguished Professor of International Health at the Rollins School of Public Health Since 1997 Faculty of Emory University Since 2000 Executive Director of Global 2000 - disease eradication and agricultural projects
Chief of the CDC Smallpox Eradication Program | |
1970 | 's key member of the successful campaign to eradicate smallpox, medical missionary in Nigeria|
1977 | Director of the U.S. Centers for Disease Control|
1984 | co-former of the Task Force for Child Survival (now: and Development), a working group for the WHO, UNICEF, The World Bank, the United Nations Development Program and the Rockefeller Foundation
Gary HART
retired from the United States Senate strategic advisor to major US corporations
Graduate of the Yale Law School, the Yale Divinity School and Southern Nazarene University | |
Visiting Fellow and McCallum Memorial Lecturer at Oxford University | |
Global Fund Lecturer at Yale University | |
Regents Lecturer at the University California | |
1974 | elected to the Senate, re-elected in 1980|
1975-1987 | Represedent the State of Colorado in the United States Senate|
Since 1988 active in negotiating ground-breaking joint venture agreements in the Commonwealth of Independent States |
Dr. Juij Leonidowitsch SCHEWTSCHENKO
1995 Beförderung zum Generaloberst der Medizinischen Dienste Seit 1999 Minister für Gesundheitswesen der Russischen Föderation
Besuch der Militärakademie für Medizin "S.M.Kirow" in Leningrad | |
1974-1975 | Führer eines Operations- und Verbandszuges eines Sanitätsbataillons in Leningrad|
1975-1976 | Stationsarzt der Klinik für Chirurgie an der Militärakademie für Medizin in Leningrad|
1976-1978 | Klinisches Ordinariat an der Militärakademie für Medizin|
1978-1980 | Stationsarzt der Klinik für Chirurgie an der Militärakademie für Medizin|
1980-1991 | Lehrer, Oberlehrer, Leiter des Instituts und der Klinik für Chirurgie der Militärakademie für Medizin|
1991-1992 | Leiter des Instituts und der Klinik für Herz- und Gefäßchirurgie der Militärakademie für Medizin
Dr. Peter SWETLY
Vizerektor, Veterinärmedizinische Universität Wien
Studium der Chemie/Physik an der Universität Wien | |
1966 | -68 Wissenschaftliche Hilfskraft am Institut für Biochemie der Universität Wien, Mitarbeit im chemischen Praktikum für Medizin|
1968 | -69 Post Doctoral Fellow, Wistar Institute for Anatomy and Biology, University of Pennsylvania, Philadelphia, USA|
1970 | -71 WHO Fellow am Wistar Institute|
1968 | -81 Laborleiter (Ernst Boehringer Institut, Wien)|
1986 | Außerordentlicher Universitätsprofessor an der Medizinischen Fakultät der Universität Wien|
1981 | -88 Leiter der Abteilung Gentechnologie (Ernst Boehringer Institut, Wien)|
Seit 1988 Direktor, Bereich Forschung und Entwicklung (Bender + Co GmbH, ab 1.1.1999 Boehringer Ingelheim Austria) |